Halozyme Therapeutics, Inc. <HALO.O>: Wells Fargo Raises Target Price to $95 From $75
HALO•Related News
Under Armour down after forecasting steeper annual revenue decline
UAA•
Baker Hughes Company <BKR.O>: Morgan Stanley resumes coverage with overweight rating; price target $70
BKR•
Haemonetics Corp <HAE.N>: Raymond James raises target price to $105 from $90
HAE•
Doximity shares surge after first-quarter revenue beats estimates
DOCS•
QumulusAI signs deal to supply Nvidia Blackwell GPU capacity to agentic hedge fund
QMLS•